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Abstract
Genetic risk factors can significantly increase chances of developing psychiatric disorders, but the underlying biological
processes through which this risk is effected remain largely unknown. Here we show that haploinsufficiency of Cyfip1,
a candidate risk gene present in the pathogenic 15q11.2(BP1–BP2) deletion may impact on psychopathology via
abnormalities in cell survival and migration of newborn neurons during postnatal hippocampal neurogenesis. We
demonstrate that haploinsufficiency of Cyfip1 leads to increased numbers of adult-born hippocampal neurons due to
reduced apoptosis, without altering proliferation. We show this is due to a cell autonomous failure of microglia to
induce apoptosis through the secretion of the appropriate factors, a previously undescribed mechanism. Furthermore,
we show an abnormal migration of adult-born neurons due to altered Arp2/3 mediated actin dynamics. Together, our
findings throw new light on how the genetic risk candidate Cyfip1 may influence the hippocampus, a brain region
with strong evidence for involvement in psychopathology.
Introduction
Many psychiatric conditions show high heritability.
Recent genetic studies in schizophrenia for example have
identified up to 160 loci that increase risk for the dis-
ease1,2 enriched within synaptic3, histone modifying and
immune system genes4. CYFIP1 is a genetic risk factor for
schizophrenia, autism and developmental delay, by virtue
of its presence in the penetrant 15q11.2(BP1–BP2) copy
number deletion5. Loss of one copy of this interval leads
to substantially increased risk for disorder in both Wes-
tern6,7 and Han Chinese populations8. CYFIP1 hap-
loinsufficiency is likely a major contributor to the 15q11.2
(BP1–BP2) psychiatric phenotype due to evidence of
CYFIP1’s involvement in a range of synaptic functions,
including key roles in dendritic spine morphology and
branching9–11. CYFIP1 protein influences synaptic func-
tion in two main ways. CYFIP1 interacts with fragile X
mental retardation 1 (FMRP), the protein gene product of
FMR1, to suppress translation of up to 800 target tran-
scripts12. Secondly, it interacts with Wiskott–Aldrich
syndrome protein family member 1 (WAVE1), a key
mediator of cytoskeleton dynamics, to modulate ARP2/3
dependant actin branching13.
In the present work we focus on microglia and adult
hippocampal neurogenesis (AHN) as important sites of
CYFIP1 action and as potential contributors to psychia-
tric phenotypes arising from 15q11.2(BP1–BP2) copy
number deletion. Adult-born hippocampal neurons, up
to 700 of which are estimated to be born per day in
humans14, develop through a well-defined series of
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cellular events, starting from proliferative stem cells
through intermediate progenitors, migratory neuroblasts
and immature neurons, before eventually forming mature
granule cells, which distribute through the dentate
gyrus15. In rodent models, adult-born hippocampal
neurons have been shown to be involved in a number of
behavioural processes, spanning pattern separation16,17,
spatial navigation18,19, memory turnover20, and acquisi-
tion21 and extinction22 of fear memory. There behaviours
are affected in psychiatric disorders including schizo-
phrenia23–26. Antipsychotic drugs, specifically atypical
antipsychotics, also impact AHN27 and importantly, a
number of functionally diverse schizophrenia risk genes,
including DISC128, SREB2/GPR8529, CACNA1C30,31
DGCR832 and miR13733, converge in their ability to
modify AHN. Additionally, post-mortem findings from
schizophrenia patients reveal changes in cell proliferation
and expression of immature neuronal markers in the
hippocampus34–36.
Immune changes are another common hallmark of
several psychiatric disorders, including schizophrenia,
where evidence from epidemiological data37,38 and find-
ings showing increased inflammatory factors in the cir-
culation39, and in post-mortem brain40 of schizophrenia
patients, implicate altered immune function in the
development of disease symptoms. Mechanistic insights
linking immune changes to risk for psychopathology are
however largely lacking. Recent interest has focused on
microglia, the resident macrophage-like immune cells of
the central nervous system, with data suggesting possible
alterations in microglial functioning in both those at high
risk and those diagnosed with schizophrenia41–44. The
causal mechanism(s) by which microglia might contribute
to pathogenesis remain unclear, though there is increasing
evidence that, in addition to canonical immune functions,
microglia also modify neuronal networks through synap-
tic pruning during development45 and into adulthood46.
This microglial-mediated pruning is important for normal
brain and behavioural functioning47. Additionally,
microglia can modulate neuronal firing through direct
cell–cell contacts48, and have been shown to be capable of
phagocytosing both developing49 and adult50 neurons.
In this work we used a translationally relevant hap-
loinsufficient mouse model to reveal hitherto unde-
scribed effects of manipulating Cyfip1 on the survival
and migration of newborn neurons in dentate gyrus
hippocampus, key cellular processes in the development
and function of the adult hippocampus. We also reveal
the mechanisms mediating these effects, highlighting
CYFIP1 effects on microglia mediated apoptosis and
Arp2/3 dependent actin dynamics, respectively. We
suggest these findings may have relevance to how Cyfip1
haploinsufficiency can influence hippocampal function
in the context of the markedly increased risk for
psychiatric disorder arising from the 15q11.2(BP1–BP2)
copy number deletion.
Materials and methods
For full Materials and methods, please see Supplemen-
tary Information.
Cyfip1 heterozygous knockout mice
Cyfip1tm2a(EUCOMM)Wtsi animals (MGI:5002986, referred
to hereafter as Cyfip1+/−) were maintained hetero-
zygously on a C57/BL6J background, for genotyping
examples, see Fig. S1. Animals used were of mixed sex and
8–12 weeks old. Cyfip1+/− and wild-type littermates were
kept in conventional cages with 12 h light–dark cycle and
ad libitum access to water and food at all time. All
experiments were performed in accordance with the
Animal (Scientific Procedures) Act 1986, and approved by
the local animal welfare committee.
Tissue harvesting and immunohistochemistry
Paraformaldehyde fixed brains from 8 to 12-week-old
Cyfip1+/− and wild-type littermates were prepared as
previously described51. Free floating 40 μm cryostat sec-
tions were used for immunohistochemistry. Immunohis-
tochemistry was performed as previously described51,
with a 1:12 stereotactic sampling rate. Detection of
cleaved-caspase 3 used a modified protocol, where pri-
mary antibodies were incubated for 48 h in blocking
solution at 4 °C. Primary and secondary antibodies are
described in Table S1.
Primary hippocampal progenitor culture
Hippocampal progenitors were isolated from P7 to P8
animals. Isolated hippocampi were dissociated in papain
and progenitors were enriched through Optiprep density
gradient centrifugation. Cells were cultured on poly-L-
lysine and laminin in the presence of EGF and FGF2.
Primary microglial culture
Microglia were isolated from P7 to P8 whole brain
mixed glia through the shake-off method.
Immunocytochemistry
Fixed cultures were blocked and permeabilized with 5%
donkey serum and 0.1% Triton X100 in PBS (PBST) for
30min at room temperature. Primary antibodies were
applied in the same solution overnight at 4 °C. Antibodies
are detailed in Table S1. Following three washes in PBST,
relevant secondary antibodies were applied in PBST for
2 h at room temperature. For identification of microglia,
Alexa 568 conjugated IB4 (ThermoFisher I21412) was
added to secondary antibody solutions at 2.5 µg/ml. Cells
were washed, counterstained with DAPI, and mounted for
microscopy.
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Conditioned medium
Microglia conditioned medium was prepared by incu-
bating 5 × 105 microglia per ml in progenitor medium for
24 h. 25% conditioned medium was added to hippocampal
cultures.
Time-lapse imaging and cell tracking
Primary hippocampal progenitors were plated on poly-
D-lysine and laminin coated 24 well plates, and cultured
for 5 days. At 5 DIV, cultures were imaged on an inverted
Leica DMI600B microscope, at 37 °C, with 5% CO2 in air.
Cells were imaged for 2 h, with image acquisition every
5 min. Total distance covered was determined through
manual cell tracking using the MTrackJ plugin in Ima-
geJ52. A minimum of 50 cells ware analysed per condition
per animal.
Actin analysis
Cells were fixed at 5 DIV with 4% paraformaldehyde in
PBS, at 4 °C for 30min, permeabilised with 0.1% Triton
X100 in PBS for 15min, and incubated with 300 nM
Alexafluor 488 conjugated DNAseI (ThermoFisher
D12371) and 200 nM Alexafluor 647 conjugated phalloi-
din (ThermoFisher A22287) for 30min. Fluorescence
intensity was measured in ImageJ.
Arp2/3 inhibition
Cells were treated with 50 μM CK-548 or 250 μM CK-
666 in DMSO, or vehicle, for 2 h prior to time-lapse
imaging. Drugs were present during imaging.
Results
Cyfip1+/− animals have normal proliferation but increased
numbers of adult-born immature neurons in the
hippocampus
We first investigated cell proliferation in the dentate
gyrus of the hippocampus. Animals received a single
injection (i.p.) of 100mg/kg BrdU 6 h prior to sacrifice.
No significant differences in cells positive for BrdU
(197.3 ± 11.1 vs. 182.9 ± 11.7 cells/mm2, t(7)= 0.86, p=
0.41) or the cell cycle marker Ki67 (422.4 ± 24.9 vs.
371.8 ± 30.8 cells/mm2, t(7)= 1.27, p= 0.25) were found
(Fig. 1A–C), indicating no effects on cell proliferation.
However, staining for the early neuronal marker dou-
blecortin (DCX) revealed a significant increase of immu-
noreactive cells in the Cyfip1+/− animals (367.0 ± 21.9 vs.
550.6 ± 39.4 cells/mm2, t(15)= 4.38, p= 6.21 × 10
−4, Fig.
1D, E), consistent with the presence of increased numbers
of immature neurons. In a 30 day BrdU pulse-chase
protocol we observed increased numbers of mature post-
mitotic BrdU+/NeuN+ labelled cells in the dentate gyrus
of Cyfip1+/− animals (42.9 ± 7.6 vs. 61.5 ± 3.9 cells/mm2,
t(10)= 4.54, p= 6.8 × 10
−4), as well as an increased frac-
tion of NeuN+ cells in the total BrdU+ population
(51.0 ± 2.7% vs. 60.5 ± 0.8%, t(10)= 3.95, p= 0.002)
(Fig. 1F–H). These data indicated that the excess numbers
of immature neurons seen in the Cyfip1+/− animals were
maintained into maturation. We found no significant
effects of sex of the animal (see Supplementary Results
and Fig. S2).
Increased neuronal numbers in Cyfip1 haploinsufficiency is
due to decreased apoptosis
To investigate the cell-intrinsic effects of Cyfip1 hap-
loinsufficiency independent of niche effects we used pri-
mary hippocampal progenitor cultures. The in vitro data
corroborated the ex vivo finding, showing an increase in
the fraction of DCX immunoreactive cells in the cultures
prepared from Cyfip1+/− animals (5.5 ± 0.5% vs. 8.8 ±
1.4%, t(16)= 2.78, p= 0.014, Fig. 2A, B) in the absence of
any effects on proliferation (see Supplementary Results
and Fig. S3). There were no differences in the proportions
of earlier progenitors of the 1/2a GFAP+/nestin+ type
(9.4 ± 1.2% vs. 10.0 ± 1.7%, t(35)= 0.76, p= 0.79), or 2b
GFAP−/nestin+/DCX− types (22.1 ± 1.6% vs. 20.2 ±
2.5%, t(35)= 0.67, p= 0.51), (Fig. 2C–E), indicating no
effects on early stages of neurogenesis. We next assessed
general cell viability and survival. We saw a significant
increase in the proportion of viable MitoTracker+ cells
(82.4 ± 1.2% vs. 89.6 ± 0.7%, t(14)= 3.23, p= 0.002) and
fewer propidium iodine positive dead/dying cells (7.7 ±
0.6% vs. 5.4 ± 0.5%, t(16)= 2.44, p= 0.026) (Fig. 2F–H).
This suggested an apototic mechanism. Indeed, we found
significantly fewer cleaved-caspase-3 immunoreactive
cells in vivo in the dentate gyrus of Cyfip1+/− animals
(2.1 ± 0.2 vs. 1.2 ± 0.1 cells/mm2, t(23)= 3.01, p= 0.006,
Fig. 2I, J). To confirm this, we investigated apoptosis
specifically in the DCX+ populations in our cultures. We
found a marked reduction in the fraction of DCX+/nestin
− cells positive for cleaved-caspase-3 (25.9 ± 5.5% vs.
7.2 ± 2.5%, t(16)= 2.32, p= 0.034, Fig. 2K, L), again
demonstrating a high level of concordance between
effects in cell culture and intact brain tissue. We found no
sex effects in any of the phenotypes investigated in the
primary cultures (see Supplementary Results and Fig. S4).
Together, these data suggested Cyfip1 haploinsufficiency
impaired a normal homoeostatic apoptotic mechanism for
modulating newborn neuron number, leading to a greater
number surviving to go on to maturity.
Evidence that apoptosis of newly born neurons is
mediated by microglia secreted factors
Given the known roles microglia play in earlier stages of
neurogenesis53, we speculated that microglia may play a
role in the survival and death of adult newborn immature
neurons. First, we established that there were no genotype
differences in density of Iba1+ microglia in hippocampus
ex vivo or in vitro (Fig. S5, in either sex). To investigate the
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role of microglia in neuronal apoptosis, we depleted
microglia from wild-type primary hippocampal progenitor
cultures using the specific microglia toxin Mac-1-SAP,
targeting CD11b expressing cells. We established the effi-
cacy of the toxin against primary mouse microglia (Fig. 3A).
Depletion of microglia from hippocampal cultures led
to an increase in the proportion of DCX+ cells (7.5 ± 1.6%
vs. 12.7 ± 0.3%, t(7)= 3.19, p= 0.019, Fig. 3B), and a spe-
cific decrease in the fraction of apoptotic DCX+ cells
(13.1 ± 3.1% vs. 2.7 ± 1.7%, t(7)= 2.93, p= 0.026, Fig. 3C),
Fig. 1 Cyfip1 haploinsufficiency increases neurogenesis in vivo in the absence of changes in proliferation. A Experimental scheme,
proliferation rates were studied with a 6 h pulse of BrdU. B Representative immunohistochemistry showing distribution and location of proliferative
(Ki67+) and dividing (Ki67+BrdU+) cells in wild-type and Cyfip1+/− animals (n= 4 each), respectively. C Quantification showed no difference in
numbers of proliferative cells or number of cell divisions. D Representative staining for DCX in wild-type and Cyfip1+/− animals (n= 8 each),
respectively. E Quantification showed a significantly larger number of immature neurons in the Cyfip1+/− animals. F Experimental scheme, cell
maturation was studied with a 30 day BrdU pulse-chase. G Representative images showing BrdU+ and NeuN+ cells. Arrowheads indicate BrdU+
cells H Cyfp1+/− animals (n= 6) had significantly higher numbers of BrdU+NeuN+ cells than the wild-type animals (n= 5). l The fraction of BrdU+
cells which had matured into NeuN+ cells was significantly increased in the Cyfip1+/− animals. All data are shown as mean ± SEM.
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Fig. 2 Primary hippocampal progenitor cultures prepared from P7 to P8 brain confirm ex vivo findings and indicate that increased
neuronal numbers in Cyfip1+/− animals is due to reduced apoptosis. A Immunoreactivity for immature neuron marker DCX and hippocampal
marker Prox1 confirm cultures contain hippocampus-derived developing neurons. B Cyfip1+/− animals showed a significantly higher proportion of DCX
+ cells in the total DAPI+ population (n= 17). C Representative staining for progenitor markers GFAP and nestin showed cultures contained a mixed
population of progenitors at differing stages of development. D There was no significant difference in the proportion of early GFAP+/nestin+ cells
(n= 36). E The proportion of later GFAP−/nestin+ cells (n= 36) was also unaffected. F Live imaging showed cultures are largely comprised of healthy,
MitoTracker+ cells, with some dying PI+ cells. G A small but significant increase in the proportion of MitoTracker+ cells was observed in the Cyfip1+/−
cultures (n= 15). H Conversely, a significant decrease in the proportion of PI+ cells was seen in the Cyfip1+/− cultures (n= 14). I Examples of apoptotic
cells in the dentate gyrus, as marked by immunoreactivity for cleaved-caspase 3. J Cyfip1+/− animals (n= 13) have significantly fewer apoptotic cells
than wild-type animals (n= 12). All data are shown as mean ± SEM. K Immunoreactivity for apoptotic marker cleaved-caspase with DCX and nestin
showed specific neuronal apoptosis in primary cultures. Arrowheads indicate an apoptotic neuron. K The fraction of immature neurons undergoing
apoptosis was significantly lower in the Cyfip1+/− cultures (n= 17). L Representative image of apoptotic cells in the dentate gyrus.
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without any associated changes in the nestin+ population
(50.7 ± 2.7% vs. 53.8 ± 1.0%, t(7)= 1.07, p= 0.32, Fig. 3D),
phenocopying the Cyfip1+/− cultures, and showing a
significant role for microglia in regulating DCX numbers.
Conversely, addition of exogenous microglia on a semi-
permeable membrane, allowing only for soluble factors to
influence neuronal apoptosis, had opposite effects. Under
these conditions we observed, a decreased proportion of
DCX+ cells (5.9 ± 0.8% vs. 1.9 ± 0.5%, t(15)= 4.36, p=
6.5 × 10−4, Fig. 3F), increased apoptosis in the DCX+
population (14.8 ± 4.7% vs. 51.7 ± 9.0%, t(15)= 3.27, p=
0.006, Fig. 3G) and no effect on the nestin+ population
Fig. 3 (See legend on next page.)
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(58.4 ± 3.3% vs. 62.7 ± 3.0%, t(15)= 0.98, p= 0.34, Fig. 3H).
These experiments provide converging evidence for a
previously unknown function of microglia in inducing
apoptosis of immature neurons in the hippocampus,
which is mediated, at least in part, by soluble factors.
Haploinsufficiency of Cyfip1 inhibits the ability of microglia
to support apoptosis of newborn immature hippocampal
neurons
Having established a novel microglial dependent
mechanism for regulation of neuronal survival, we next
tested whether effects on this process could underlie the
effects of Cyfip1 haploinsufficiency on neuronal survival.
To directly address the potential role the induction of
apoptosis by microglial secreted factors in an unbiased
way, we used a cross-genotype conditioned medium
approach. Medium obtained from isolated wild-type and
Cyfip1+/− microglia preparations was added to both the
wild-type and Cyfip1+/− hippocampal progenitor enri-
ched cultures (see Fig. 3I, M for schematic of design)
and cell proportions and levels of apoptosis were
determined. In the wild-type progenitor cultures, adding
conditioned medium from wild-type microglia resulted
in a significant reduction in the proportion of
DCX+ cells, compared to unstimulated cells, whereas
Cyfip1+/− conditioned medium had no effect (5.4 ± 0.9%
vs. 2.9 ± 0.2% vs. 5.4 ± 0.3% for unstimulated, wild-type
stimulated and Cyfip1+/− stimulated respectively, main
effects of genotype F(2,9)= 6.31, p= 0.019, Fig. 3J). Post
hoc testing confirmed significant differences between
controls and wild-type medium (p= 0.031) and between
those stimulated with wild-type and Cyfip1+/− medium
(p= 0.033). This pattern of effects was mirrored inver-
sely in the fraction of DCX+ cells that were also
immunopositive for cleaved-caspase-3, with only
conditioned medium from wild-type microglia cultures
increasing apoptosis (16.1 ± 3.6% vs. 34.5 ± 3.5% vs.
14.8 ± 2.5%, main effects of genotype F(2,9)= 11.57, p=
0.003, Fig. 3K). Again, post hoc testing showed the wild-
type stimulated condition was significantly different
from controls and Cyfip1+/− stimulated condition (p=
0.007 and p= 0.005, respectively). Consistent with the
conclusion that these effects were limited to the DCX+
immature neuron population of cells, the proportion of
cultures that was nestin+ was unchanged across all
conditions (65.0 ± 5.2% vs. 60.7 ± 4.4% vs. 57.1 ± 4.1%,
F(2,9)= 0.75, p= 0.50, Fig. 3L).
Importantly, identical patterns of effects were seen in
the Cyfip1+/− hippocampal progenitor cultures. Using an
identical experimental design (Fig. 3M), we found that
conditioned medium from wild-type microglia, but not
from Cyfip1+/− microglia, decreased the proportion of
DCX+ cells (8.1 ± 0.6% vs. 5.1 ± 0.2% vs. 9.0 ± 0.7%, main
effects of genotype F(2,9)= 13.82, p= 0.002, Fig. 3N) with
post hoc analysis confirming wild-type microglia medium
stimulated conditions were significantly different from
control and Cyfip1+/– stimulated conditions (p= 0.008
and p= 0.002, respectively). Similarly, only conditioned
medium from wild-type microglia was associated with a
significant increase in the proportion of apoptotic DCX+
cells (12.8 ± 2.3% vs. 28.3 ± 5.0% vs. 13.0 ± 0.9%, main
effects of genotype F(2,9)= 6.12, p= 0.021, Fig. 3O) with
post hoc analysis confirming the wild-type stimulated
condition was significantly different from the uncondi-
tioned medium controls and Cyfip1+/− stimulated con-
dition (p= 0.007 and p= 0.005, respectively). As before,
no effect of any of the medium conditions was seen on the
nestin-positive population (64.7 ± 2.6% vs. 64.0 ± 2.3% vs.
57.5 ± 3.3%, F(2,9)= 2.13, p= 0.18, Fig. 3P). These data
provide converging evidence for induction of neuronal
(see figure on previous page)
Fig. 3 Cyfip1 haploinsufficiency affects the ability if microglia to regulate number and apoptosis rates of immature neurons. A Experimental
setup, Mac-1-Sap was present in wild-type hippocampal progenitor cultures from 2 h after isolation until 3 days in vitro. Dose–response curves of
microglial death after Mac-1-SAP administration show near-complete depletion of Iba1+ microglia was achieved within 48 h (n= 6). B Cultures
where microglia were depleted (n= 4) showed a higher proportion of DCX+ cells than controls (n= 4). C Correspondingly, the fraction of DCX cells
undergoing apoptosis, as marked by cleaved-caspase 3 staining, was significantly decreased in the absence of microglia. D The proportion of nestin+
cells was unaffected by microglia depletion. E Experimental setup, membrane inserts containing wild-type microglia prepared from P7–8 brain were
added to cultures 2 h after progenitor isolation and were present throughout the remainder of the experiment. Due to the experimental conditions,
no cell–cell contact between microglia and progenitors was possible, but secreted factors were free to diffuse. F The presence of microglia-
containing inserts (n= 8) significantly decreased the proportion of DCX expressing cells compared to controls (n= 8). G Conversely, the added
microglia significantly increased apoptosis in DCX+ cells. H No effect was seen in nestin expressing cells. I Experimental design, wild-type
hippocampal progenitors were exposed to conditioned medium from either wild-type or Cyfip1+/− microglia. J In wild-type cultures, conditioned
medium from wild-type microglia induced a significant reduction in the proportion of DCX+ cells, whereas medium from Cyfip1+/− microglia was
unable to do this (n= 4 in all conditions). K An inverse pattern was seen in neuronal apoptosis where wild-type microglia medium increased
apoptosis in DCX+ immature neurons but Cyfip1+/– medium did not. L Nestin+ cells were not significantly affected by the presence of microglial
factors. M Experimental design, Cyfip1+/− hippocampal progenitors were exposed to conditioned medium from either wild-type or Cyfip1+/−
microglia. N As seen in the wild-type cultures, a significant decrease in DCX+ cells was observed only after stimulation with medium from wild-type
microglia (n= 4 in all conditions). O Similarly, medium from Cyfip1+/− microglia was unable to induce apoptosis in Cyfip1+/− progenitors. P Again,
the nestin+ population was unaffected. All data are shown as mean ± SEM.
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apoptosis through factors secreted by microglia a process
which is disrupted in Cyfip1+/− animals.
Proliferative cells are abnormally positioned in the
Cyfip1+/− hippocampus
As well as having to survive, newborn cells have to
migrate to the correct location to functionally integrate
into existing hippocampal circuitry. We noted that the
gross positioning of newborn cells appeared different in
the Cyfip1+/− animals. Cells undergoing proliferation are
normally largely limited to the subgranular zone (SGZ) of
the dentate gyrus, apart from some radially migrating
neuroblasts undergoing their final divisions. Indeed, the
majority of Ki67+ cells were found in the SGZ, however a
significantly larger fraction was found in the SGZ in the
Cyfip1+/− animals (Fig. 4A, B, 80.4 ± 1.1% vs. 88.2 ± 0.6%,
t(14)= 6.001, p= 3.2 × 10
−5). As well as an increased
fraction remaining in the SGZ, Cyfip1+/− Ki67+ cells
were also found significantly less far out into the granular
zone (Fig. 4C, 17.0 ± 1.4 µm vs. 11.9 ± 1.0 µm, t(14)=
2.999, p= 0.009). These data suggested a migration deficit
in Cyfip1+/− animals.
Cyfip1+/− adult-born neurons show impaired migration
into the granular layer
In order to gain direct evidence of abnormal migration
in Cyfip1+/− animals we tracked the final positioning of
newly born neurons using a 30 day BrdU pulse-chase
paradigm followed by staining for BrdU/Neun. Neurons
born in the SGZ normally undergo a radial migration
outwards into the granular layer. Consistent with a
migration deficit in the Cyfip1+/− animals we found a
greater proportion of BrdU+NeuN+ cells had remained
in the SGZ in (Fig. 4D, E, 52.2 ± 3.6% vs. 66.7 ± 2.8%,
t(12)= 3.197, p= 0.008) and those cells that had migrated
had moved a smaller distance into the granular zone (Fig.
4F, 13.6 ± 2.3 µm vs. 6.0 ± 0.7 µm, t(12)= 3.549, p= 0.004).
When we further analysed the location of the BrdU+
/NeuN+ cells that had left the SGZ by dividing the
dentate gyrus into four quartiles mapping on to the route
taken by migrating cells, we found that the distribution of
cells over these quartiles was significantly different
(Fig. S6, χ2= 25.7, p= 1.1 × 10−5) and, as would be
anticipated with a migration deficit, BrdU+/NeuN+ cells
in the Cyfip1+/− animals were skewed towards the two
most proximal quartiles (i.e. those closest to the starting
point in the SGZ). Finally, we examined the putative
migration phenotype observed in vivo by performing
time-lapse imaging in primary hippocampal cultures.
Over the 2 h imaging period, Cyfip1+/− cells covered
significantly less distance than wild-type cells (Fig. 4G, H,
133.0 ± 4.7 vs. 90.7 ± 12.0 µm, t(10)= 3.993, p= 0.003).
Both the in vivo and in vitro findings were consistent with
a migration deficit due to Cyfip1 haploinsufficiency.
Actin dynamics are altered in Cyfip1+/− cells and inhibition
of Arp2/3 activity rescues migration deficits in vitro
As CYFIP1 contributes to the regulation of actin
branching and polymerisation through the WAVE1
complex, a function crucial for cytoskeletal reorganisation
and cell migration, we speculated that the Cyfip1+/−
related migration phenotype was related to alterations in
actin dynamics. A main determinant of actin function in
the context of cytoskeleton reorganisation is the ratio of
filamentous (F) to globular (G) actin. We first checked
this ratio in primary hippocampal cultures, staining with
fluorescently labelled phalloidin for F-actin and DNAse1
for G-actin, and found a significant increase in F-G-actin
ratio in Cyfip1+/− cells (Fig. 5A, B, 0.67 ± 0.3 vs. 1.48 ±
0.28, t(5)= 2.904, p= 0.034). An increase in F-G-actin
ratio would be consistent with concurrent increased
activity in Arp2/3 brought about by an expected reduction
of CYFIP1-WAVE1 complexing under conditions of
Cyfip1 haploinsufficiency. Hence, we further speculated
that treatment with Arp2/3 inhibitors would influence,
and potentially rescue, the abnormal cell migration phe-
notypes in Cyfip1+/− cultures. To do this we used two
drugs; CK-548, which induces a conformation change
inhibiting actin binding and CK-666, which stabilises the
inactive form of Arp2/3.
Analysis by time-lapse imaging showed that both drugs
were effective in influencing cell migration. However, the
effects were essentially opposite in wild-type and
Cyfip1+/− cultures. In wild-type cultures, treatment with
Arp2/3 inhibitors had a significant effect on migration
(Fig. 5C, vehicle: 107.3 ± 5.6, CK-548:76.3 ± 3.9, CK-666:
65.2 ± 5.4 μm, F(2,24)= 18.91, p= 1.17 × 10
−5), with both
CK-548 and CK-666 showing significant decreases in
distance moved (p= 5.8 × 10-4 and 1.1 × 10−5, respec-
tively). In Cyfip1+/− cultures, there was also a significant
effect on migration by Arp2/3 inhibitors (Vehicle:
68.1.3 ± 4.4, CK-548:117.2 ± 8.8, CK-666:112.0 ± 9.8 μm,
F(2,6)= 11.39, p= 0.009). In contrast to wild-type cul-
tures, both CK-548 and CK-666 caused significant
increases in distance moved (p= 0.011 and p= 0.019,
respectively), restoring migration to wild-type levels and
suggesting excessive Arp2/3 activity was responsible for
the migration deficit in Cyfip1+/− cells.
Discussion
We have shown changes in the survival and migration
of newly born neurons in hippocampus in a model of
Cyfip1 haploinsufficiency, recapitulating the lowered gene
dosage found in the pathogenic 15q11.2(BP1–BP2) copy
number deletion. We report that Cyfip1+/− animals have
larger numbers of surviving newly born neurons in hip-
pocampus, in the absence of increases in numbers of stem
cells or rate of proliferation, and provide evidence that
this is the result of a specific failure in microglia-induced
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apoptosis (see summary of proposed mechanism in
Fig. S7). These newly born neurons also show an Arp2/3
dependent deficit in migration, resulting in a failure to
reach their appropriate locations within the dentate gyrus.
Our study is the first to our knowledge to demonstrate a
direct effect of microglial soluble factors on the survival of
immature neurons as a homoeostatic mechanism. In
contrast to earlier findings examining the effect of
microglia on adult neurogenesis54–56, we show this occurs
in the absence of overt inflammatory disease or microglial
activation. Our data indicate this is a mechanism sus-
ceptible to pathogenic changes, as evidenced by the effects
of Cyfip1 haploinsufficiency on the ability of microglia to
regulate apoptosis of immature neurons.
Fig. 4 Altered migration of immature Cyfip1+/− neurons. A Immunohistochemistry for the Ki67, showing cells in the cell cycle, shows the majority
are located in the SGZ (closed arrowheads), but some are starting to move out into the granular layer (open arrowheads). B A significantly larger
fraction of Ki67+ cells are located in the SGZ in Cyfip1+/− animals, comparted to wild types. C The distance moved from the SGZ is significantly lower
in the Cyfip1+/− animals, comparted to wild types. D Post-mitotic adult-born neurons (NeuN+/BrdU+) are located predominantly in the granular
layer (open arrowheads), but some are still located in or near the SGZ (closed arrowheads). E As with Ki67+ cells, a smaller fraction of Cyfip1+/− cells
are in the granular layer. F Distance moved by these cells is significantly lower. G Time-lapse imagining shows the movement of cells in primary
hippocampal cultures. H Quantification of cell movement during live imaging shows a significantly smaller distance moved by the Cyfip1+/− cells.
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The effects of Cyfip1 haploinsufficiency were highly
cell-type specific and appeared limited to the stage of cell
maturity where neuronal progenitors are fully committed
to a neuronal phenotype, a stage of development char-
acterised by high levels of apoptosis. Whilst we have
demonstrated that soluble factors from microglia are
involved in controlling numbers of immature neurons
during adult neurogenesis, and that haploinsufficiency of
Cyfip1 leads to reduced apoptosis via an effect on factors
secreted from microglia, the soluble factor(s) responsible
remain to be identified. Future proteomic and pharma-
cological work will serve to identify and validate the
identity of the responsible medatior(s). Cyfip1 has pleo-
tropic roles but the potential links between CYFIP1, actin
remodelling. and cytokine secretion are especially inter-
esting57. A focus for CYFIP1 action in microglia gains
further evidence from a recent preprint by showing the
effect of cell specific deletion of Cyfip1 on microglia
morphology, movement and function58.
In parallel, we have shown that adult-born neurons in
Cyfip1+/− animals show a significantly impaired migra-
tion phenotype. Here our data point to a key role for
CYFIP1 effects on actin dynamics mediated by Arp2/3
activity. We hypothesise that lowered dosage will lead to
reduced engagement of CYFIP protein with the CYFIP-
WAVE1-Arp2/3 pathway resulting in reduced suppres-
sion of Arp2/3 activity and abnormal actin cytoskeleton
remodelling required for migration. We show evidence to
support this hypothesis though, as predicted, an increase
in F-G-actin ratio and rescue of the migration phenotype
by pharmacological inhibition of Arp2/3 activity. The
activation of the WAVE-Arp2/3 system is complex and,
can take place in at least two different Rac1 mediated
pathways59,60. It is unlikely that CYFIP1 is the sole
Fig. 5 Disruption of Arp2/3 mediated actin dynamics is responsible for migration deficit. A Fluorescently labelled phalloidin and DNAse show
the amount of filamentous and globular actin, respectively. B Quantification of fluorescence intensity shows Cyfip1+/− cells have an increased F- to G-
actin ratio. C Treatment with Arp2/3 inhibitors CK-548 or CK-666 in wild-type cells significantly reduces the distance moved by cells during live
imagine, whereas treatment of Cyfip1+/− cells restores distances to wild-type levels.
Haan et al. Translational Psychiatry          (2021) 11:313 Page 10 of 12
regulator of this activation, but our data point towards a
significant role in this process.
The combined effects of failure to undergo homoeo-
static apoptosis and failure to migrate to the correct
location is likely to have profound effects on the func-
tionality of adult-born neurons in hippocampus.. We
observed lasting effects up to 30 days post division, when
adult-born neurons will already have local connec-
tions61. The prolonged survival and expression of mature
markers of these ectopic cells makes it likely these cells
will be active, indeed, it is known that synaptic NMADR
signalling is required for neuronal survival prior to this
developmental timepoint62, making it likely these cells
are integrated in some form in the local circuitry. The
exact functional consequences on a network level are
difficult to predict and will require further electro-
physiological study, both on the individual cell and
network level. Haploinsufficiency of Cyfip1 has been
shown to have disease relevant behavioural con-
sequences in both mice63,64 and rat65 models, but to
date, much of the neurobiology and behaviour in these
models has remained unexplored. Our data would
indicate a focus on hippocampal circuitry would prove of
interest. Neuronal migration in the hippocampus has, to
our knowledge, not been examined in patient popula-
tions. However, as AHN does take place in humans, and
the biochemical pathways relevant to this study are well
conserved, it is likely similar deficits would be observed
in 15q11.2BP1–BP2 carriers.
The 15q11.2(BP1–BP2) deletion is not solely associated
with schizophrenia, it also markedly increases risk for
autism spectrum disorders66, ADHD and developmental
delay67 and epilepsy68. Whether altered microglia func-
tioning due to Cyfip1 haploinsufficiency, impacting on
AHN, also plays a part in these disorders is an open
question, but all have been associated with alterations in
immune system and microglia functioning69,70. Likewise,
alterations in migration would have equally profound
consequences in other disorders.
As noted previously, a number of other schizophrenia
risk genes have also been shown to modify AHN in model
systems. Whilst the effects are distinct from those of
Cyfip1, each risk gene impacting on neurogenesis in its
own way, this convergence of function may be indicative
of a common pathogenic route for a number of diverse
psychiatric risk genes.
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